Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant

Clinical trial NCT00141726 · COMPLETED

Trial details

NCT number: NCT00141726
Sponsor: University of Michigan Rogel Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Injury, Acute Respiratory Distress Syndrome, Adult Bronchiolitis Obliterans

Start date: 2003-10-01
Primary completion: 2008-07-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.